Navigation Links
Revised AVMA Policy on Castrating and Dehorning Cattle Provides Additional Guidance for Managing Pain
Date:5/12/2008

SCHAUMBURG, Ill., May 12 /PRNewswire-USNewswire/ -- The American Veterinary Medical Association (AVMA) has revised its policy on castration and dehorning of cattle to provide veterinarians with additional guidance for managing pain associated with these procedures. The revised policy, approved on April 12, 2008, does not dictate that practitioners use any particular method of pain management or drug. Instead it provides some basic recommendations for consideration by practitioners when they work with producers to achieve the goal of pain management.

Revisions made to the policy are the result of a comprehensive review of recent science that has provided more information about identifying and ameliorating pain experienced by cattle during castration and dehorning.

"Individual practitioners are encouraged to achieve pain management, when possible, using their education, experience and judgment," says Dr. Gail Golab, director of the AVMA Animal Welfare Division. "Administration of appropriate medications is one potential strategy; however, effective pain control does not always require the use of medications. It is also possible to mitigate pain by selecting a better technique or by applying a technique at a more appropriate age."

According to Dr. James Reynolds, a member of the AVMA Animal Welfare Committee and a bovine practitioner, the revised policy specifically respects the ability of veterinarians to determine the best way to mitigate pain in their patients on a case-by-case basis.

"The AVMA is not trying to dictate medical procedures, but it is the role of the AVMA to advise veterinarians on contemporary research," explains Dr. Reynolds. "With respect to dehorning and castration, current research supports this revised policy."

Dr. Reynolds reiterated that the revised policy does not suggest that pain medications must be used. For example, disbudding cattle within the first few weeks of life reduces pain compared with rem
'/>"/>

SOURCE American Veterinary Medical Association
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Revised California Stem Cell Research Rules Fail to Ensure Affordable Access to Cures, Consumers Warn
2. Chest Compressions Key to Revised CPR Guidelines
3. Schedules Revised for Flu, Meningitis Vaccines
4. Mayo researchers say ECG standards should be revised for elderly
5. Mayo Researchers Say ECG Standards Should Be Revised for Elderly
6. USP announces revised glycerin monograph
7. QED International Associates Announces Changes to the HealthShares(TM) Cardio Devices Index (As Revised)
8. GPhAs 2007 Annual Policy Conference Features Top Generic Industry CEOs; FDA, Government Officials; Wall Street Analysts
9. Chinas 1-child policy could backfire on its elderly
10. Education Key Focus of Michigan Policy Summit
11. Consumer Group: Hillary Clintons Mandatory Health Insurance Purchase Plan is an Act of War on the Middle Class Family That Cant Afford $12k Policy

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2009)...pper sequestering drug tetrathiomolybdate (TM) has...tment of Wilson disease, a disease caused by an ov...That much is known. Very little, however, is known..., A new study led by Northwestern University res...three-dimensional structure of TM bound to copper-...
(Date:11/26/2009)... Dr. David Kim of the Live Life A...ery in Dallas , is one of a growing number of phys... networking sites to connect with individuals who ...o fight morbid obesity. Dr. Kim is utilizing Faceb...on about his practice with the community. , ...
(Date:11/25/2009)...EDINA,Minn.,Nov.25/PRNewswire-USNewswire/--Whenmos...utachiropractorcanalsogivepatientsthehelptheyneed....reyourjaw(mandible)contacts/connectswithyourskull(...edwithTMJdysfunctionarepainwithchewing,clickingorp...TMJdysfunctionincluding:headaches,fatigue,sleepdis...
(Date:11/25/2009)...TORONTO,Nov.25/PRNewswire/-SentinelleMedicalInc.,a...alizationsoftwarelaunchesasuiteofnewleadingedgecli...areplatformatthisyear,sRadiologicalSocietyofNorthA...09(Booth5800,HallA).Theapplicationsleveragetheuniq...zedMRIimagingcoilsandsupportmultipleimagingmodalit...
(Date:11/25/2009)...SANFRANCISCO,Nov.25/PRNewswire/--TheBayAreaAirQual...ter Spare the Air Alert forThursday,...relogsoranyothersolidfuel,bothindoorsandoutdoors. ...irqualitytomorrow,"saidJackBroadbent,executiveoffi...respectthehealthoftheirneighborsandfellowcommunity...
Breaking Medicine News(10 mins):Health News:Research sheds light on workings of anti-cancer drug 2Health News:Research sheds light on workings of anti-cancer drug 3Health News:Dallas Texas Weight Loss Surgeon Using Social Media To Reach Out to Patients 2Health News:Dallas Texas Weight Loss Surgeon Using Social Media To Reach Out to Patients 3Health News:Sentinelle Medical Launches Aegis Suite of Oncology 4D Visualization Software with PureWeb(TM) Technology 2Health News:Sentinelle Medical Launches Aegis Suite of Oncology 4D Visualization Software with PureWeb(TM) Technology 3Health News:Winter Spare the Air Alert in Effect for Thursday, November 26, 2009 2
...Journal study finds natural, less expensive treatm...fferers , , PRINCETON, N.J., Dec. 2 With its... season is, for most, anticipated with excitement....rassing and debilitating gastrointestinal attacks,...
... PA. Patients treated with radiation prior to su...ces of cancer recurrence and better overall surviv..., The report examined a treatment called neoadjuv...chemotherapy and/or radiation. , Neoadjuvant the...
... Findings published in the December 1, 2008, issue...merican Association for Cancer Research, show lapa...cer, while women with HER2-negative breast cancer ...percent prevents some people from receiving optima...
... Dec. 2 /PRNewswire-FirstCall/ - NUCRYST Pharmaceu...cal products that fight infection and inflammation...received from its majority shareholder, The Westai...reholders. This equates to a return of capital of ...
... 2 Today Pascal Metrics Inc.,publicly announces i...agement,services for hospitals and healthcare syst...pidly has become a worldwide leader for clients se...safer from,medical failure and errors. , Acc...
...Barotz Dental is now one of only two dental,practi...ew Attachment,Procedure). This is the only laser ...proved for new attachment of gum and bone tissue a...nd discomfort to the,patient, closes the periodont...
Other Medicine News:Health News:Holiday Season Brings New Hope to Millions Who Suffer from Common Chronic Health Disorder 2Health News:HER2 levels may aid in treatment selection for metastatic breast cancer 2Health News:NUCRYST Receives Requisition to Call a Special Meeting of Shareholders From Majority Shareholder 2Health News:NUCRYST Receives Requisition to Call a Special Meeting of Shareholders From Majority Shareholder 3Health News:Pascal Metrics Announces Patient Safety Culture Services Offering 2Health News:Barotz Dental Now Offering Laser Gum Therapy 2
(Date:11/25/2009)...,, PRINCETON,N.J.,Nov.25/PRNewswire-FirstCal...harmaceuticalcompanycommittedtodiscovering,develop...ons,reportedfinancialresultsforthefiscalyearendedS...8.4millionincash,cashequivalentsandshortterminvest..., RG7128 ,, Phase2bTrial ,, InlateNov...
(Date:11/25/2009)...,, WESTPALMBEACH,Fla.,Nov.25/PRNewswire-Firs...cans,especiallythe27millionlivingwithuntreated hea...ologistCindyBeyer. ,, Dr.Beyer,seniorvicepresid...ingcareand hearingaids companies,saidstudieshaveli...tion,"whichcaneasilybeintensifiedatholidaygatherin...
(Date:11/25/2009)...,, NEWYORK,Nov.25/PRNewswire/--Reportlinker....einitscatalogue: ,, UnitedStatesDentalDevicesM....reportlinker.com/p0158733/United-States-Dental-De...,, UnitedStatesDentalDevicesMarketAnalysisandFo...essentialsourceforin-depthinformationanddatarelati...
Breaking Medicine Technology:Pharmasset Reports Fiscal Year End 2009 Financial Results 2Pharmasset Reports Fiscal Year End 2009 Financial Results 3Pharmasset Reports Fiscal Year End 2009 Financial Results 4Pharmasset Reports Fiscal Year End 2009 Financial Results 5Pharmasset Reports Fiscal Year End 2009 Financial Results 6Pharmasset Reports Fiscal Year End 2009 Financial Results 7Pharmasset Reports Fiscal Year End 2009 Financial Results 8For Millions With Untreated Hearing Loss, Holiday Season Can be Especially Difficult 2Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 2Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 3Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 4Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 5Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 6Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 7Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 8Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 9Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 10Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 11Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 12UCLA cancer researchers develop model that may help identify cancer stem cells 8850 1UCLA cancer researchers develop model that may help identify cancer stem cells 8850 2UCLA cancer researchers develop model that may help identify cancer stem cells 8850 3Tropicana Launches Get Your Fruit On 21 Campaign to Help Narrow the Gap in the Nations Fruit Consumption 49028 1Tropicana Launches Get Your Fruit On 21 Campaign to Help Narrow the Gap in the Nations Fruit Consumption 49028 2Tropicana Launches Get Your Fruit On 21 Campaign to Help Narrow the Gap in the Nations Fruit Consumption 49028 3Tropicana Launches Get Your Fruit On 21 Campaign to Help Narrow the Gap in the Nations Fruit Consumption 49028 4CEL SCI Scientist Invited to Discuss Plans to Launch Unique Manufacturing Process That Saves Cost While Enhancing the Shelf Life of Drugs at 5th Annua 49026 1CEL SCI Scientist Invited to Discuss Plans to Launch Unique Manufacturing Process That Saves Cost While Enhancing the Shelf Life of Drugs at 5th Annua 49026 2CEL SCI Scientist Invited to Discuss Plans to Launch Unique Manufacturing Process That Saves Cost While Enhancing the Shelf Life of Drugs at 5th Annua 49026 3CEL SCI Scientist Invited to Discuss Plans to Launch Unique Manufacturing Process That Saves Cost While Enhancing the Shelf Life of Drugs at 5th Annua 49026 4CEL SCI Scientist Invited to Discuss Plans to Launch Unique Manufacturing Process That Saves Cost While Enhancing the Shelf Life of Drugs at 5th Annua 49026 5
...sented at the 2008 iSBTc Annual Meeting -, - Conf... discuss,results -, BRANFORD, Conn., Nov. 3 Cura...reliminary data from an ongoing Phase II,trial of ...ets GPNMB, for,the treatment of patients with unre...ck Hwu, Co-Principal Investigator, and Professor a...
...cent of patients achieve undetectable viral load i...ment with standard of care, SAN FRANCISCO, Nov. 1...435, an investigational protease inhibitor (PI) be... chronic hepatitis C virus,(HCV) infection. Tibote...including a late-breaker poster on the proof-of-pr...
Other Medicine Technology:CuraGen Announces Preliminary Data from Ongoing Phase II Study Showing Clinical Activity of CR011-vcMMAE in Patients with Metastatic Melanoma 2CuraGen Announces Preliminary Data from Ongoing Phase II Study Showing Clinical Activity of CR011-vcMMAE in Patients with Metastatic Melanoma 3CuraGen Announces Preliminary Data from Ongoing Phase II Study Showing Clinical Activity of CR011-vcMMAE in Patients with Metastatic Melanoma 4CuraGen Announces Preliminary Data from Ongoing Phase II Study Showing Clinical Activity of CR011-vcMMAE in Patients with Metastatic Melanoma 5CuraGen Announces Preliminary Data from Ongoing Phase II Study Showing Clinical Activity of CR011-vcMMAE in Patients with Metastatic Melanoma 6CuraGen Announces Preliminary Data from Ongoing Phase II Study Showing Clinical Activity of CR011-vcMMAE in Patients with Metastatic Melanoma 7Tibotec Presents Interim Findings for TMC435, an Investigational Genotype 1 Hepatitis C Treatment, at the AASLD Liver Meeting 2008 2Tibotec Presents Interim Findings for TMC435, an Investigational Genotype 1 Hepatitis C Treatment, at the AASLD Liver Meeting 2008 3Tibotec Presents Interim Findings for TMC435, an Investigational Genotype 1 Hepatitis C Treatment, at the AASLD Liver Meeting 2008 4Tibotec Presents Interim Findings for TMC435, an Investigational Genotype 1 Hepatitis C Treatment, at the AASLD Liver Meeting 2008 5
...ormat) microfiltration units provide a reproducibl...lution onto nitrocellulose or Zeta-Probe membrane....y using interchangeable templates to form the 96-w...ot SF apparatus. Each is available as a complete, ...
...ormat) microfiltration units provide a reproducibl...lution onto nitrocellulose or Zeta-Probe membrane....y using interchangeable templates to form the 96-w...ot SF apparatus. Each is available as a complete, ...
Dot Blotting Apparatus
...orous vacuum plate, reservoir seal O-ring, sealing.... The Model 785 vacuum blotter quickly and effici...o a nylon membrane. Because it generally requires ... can be separated on a gel, transferred to a membr...
Medicine Products: